Archive

Breaking down cancer’s defences

Written by Charlie King | 5 Dec 2021

Bacteria generally have a bad reputation, as people first think of certain strains that can cause serious illnesses like pneumonia or meningitis. However, there are many helpful bacteria,… read more.

Vulnerable populations not receiving cancer survivorship care plans

Written by Charlie King | 20 Nov 2021

Study identified which groups were less likely to receive plans Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back… read more.

Study introduces new strategy to treat advanced liver cancer

Written by Charlie King | 19 Nov 2021

Advanced liver cancer, or hepatocellular carcinoma (HCC), currently has limited treatment options and poor prognosis • A recent study introduces a new approach to treat advanced HCC by… read more.

Lung cancer screening for survivors of head and neck cancer

Written by Charlie King | 11 Nov 2021

Head and neck cancer survivors with long smoking histories had a 2.5-fold greater risk of developing lung cancer than those without prior head and neck cancer, according to… read more.

Phase III monarchE trial of Verzenio in breast cancer published in Annals of Oncology – Eli Lilly

Written by Charlie King | 25 Oct 2021

Eli Lilly announced updated data from the positive Phase III monarchE trial evaluating the investigational use of Verzenio (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) for… read more.

“Never smoker” lung cancer could respond to drugs already available

Written by Bruce Sylvester | 6 Oct 2021

Drugs which are already (U.S.) Food and Drug Administration (FDA) approved could be effective in treating of lung cancer in “never-smokers,” researchers reported on Sept. 30, 2021 in… read more.

BeiGene receives positive CHMP opinion for Brukinsa for the treatment of adults with Waldenström’s macroglobulinemia

Written by Charlie King | 2 Oct 2021

BeiGene has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib)… read more.

Free radicals linked to heart damage caused by cancer

Written by Charlie King | 1 Oct 2021

In fruit flies, antioxidants reverse tumor-related cardiac dysfunction. Ohio State University A new study in animal models shows that the presence of a cancer tumor alone can lead… read more.

Study: Colon cancer risk extends to second and third-degree relatives

Written by Charlie King | 25 Sep 2021

BUFFALO, N.Y. — Having second- or third-degree relatives with colorectal cancer increases a person’s risk of developing the disease, according to the findings of a study led by… read more.

Engineers grow pancreatic ‘organoids’ that mimic the real thing

Written by Charlie King | 23 Sep 2021

Massachusetts Institute of Technology MIT engineers, in collaboration with scientists at Cancer Research UK Manchester Institute, have developed a new way to grow tiny replicas of the pancreas,… read more.

NHS launches world first trial for for new Galleri test to detect cancer

Written by Charlie King | 17 Sep 2021

The NHS will launch the world’s largest trial of a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear. The first… read more.

SOPHIA Phase III study of Margenza announces final OS data in HER2-positive breast cancer patients – MacroGenics

Written by Charlie King | 15 Sep 2021

MacroGenics announced the final overall survival (OS) results of the SOPHIA Phase III study of Margenza (margetuximab-cmkb) in adult patients with metastatic HER2-positive breast cancer. The final OS… read more.

« Previous 1 … 32 33 34 35 36 … 53 Next »

Archive

Subscribe for our mailing list

Follow Us